These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 4024808)

  • 21. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
    Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
    Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ecogenetic studies of drug acetylation in man and rats.
    Dubbels R; Khoory R; Schloot W
    Acta Anthropogenet; 1981; 5(2):111-8. PubMed ID: 7271997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster.
    Hein DW; Omichinski JG; Brewer JA; Weber WW
    J Pharmacol Exp Ther; 1982 Jan; 220(1):8-15. PubMed ID: 7053425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [N-acetyltransferase genetic polymorphism and its role in the development of neoplastic disease].
    Lutz W
    Med Pr; 2000; 51(3):277-84. PubMed ID: 11002474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphic N-acetylation of phenelzine and monoacetylhydrazine by highly purified rabbit liver isoniazid N-acetyltransferase.
    Hein DW; Weber WW
    Drug Metab Dispos; 1982; 10(3):225-9. PubMed ID: 6125354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Testing for heterogeneity in genetic polymorphism of N-acetylation using isoniazid by metameters--probit, logit, and arcsine transformation].
    Kohno H; Mori M; Katayama T
    Kekkaku; 1993 Aug; 68(8):511-6. PubMed ID: 8377325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Polymorphic acetylation in women with genital neoplasms].
    Tomaszkiewicz T; Markowska J; Simm S; Herwichowska K
    Pol Tyg Lek; 1979 Sep; 34(39):1521-3. PubMed ID: 503961
    [No Abstract]   [Full Text] [Related]  

  • 29. [Breast neoplasms and polymorphic acetylation].
    Kociałkowski K; Grodecka-Gazdecka S; Górny A
    Ginekol Pol; 1984 Jul; 55(7):517-21. PubMed ID: 6526326
    [No Abstract]   [Full Text] [Related]  

  • 30. N-acetyltransferase activity as a possible criterion in prognosing the anti-tumor effect of cyclophosphamide.
    Bulovskaya LN; Kolosov AI; Krupkin RG
    Oncology; 1979; 36(3):130-3. PubMed ID: 471424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue.
    Feldblum S; Rougier A; Loiseau H; Loiseau P; Cohadon F; Morselli PL; Lloyd KG
    Epilepsia; 1988; 29(5):523-9. PubMed ID: 3409840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Accidental epileptic crises. Importance of drugs and the genetic factor in their presentation].
    Burcet Darde J
    Neurologia; 1992 Oct; 7(8):238-9. PubMed ID: 1449845
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ontogenetic factors in epilepsy polymorphism].
    Ritsner MS; Toĭtman LL
    Sov Med; 1987; (1):86-8. PubMed ID: 3563653
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum and red-cell phenotypes in epilepsy.
    Rundle AT; Sudell B; Qazi HS
    Lancet; 1972 Dec; 2(7790):1316. PubMed ID: 4117847
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of N-acetyltransferase in patients with malignant lymphomas.
    Chekharina YeA ; Bulovskaya LN; Pavlova MV; Krupkin RG
    Neoplasma; 1978; 25(4):471-5. PubMed ID: 692806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation.
    Oyama T; Kawamoto T; Mizoue T; Yasumoto K; Kodama Y; Mitsudomi T
    Anticancer Res; 1997; 17(1B):577-81. PubMed ID: 9066583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [N-acetylation polymorphism versus differentiation of organic susceptibility to carcinogenic effect of homo- and heterocyclic aromatic amines].
    Lutz W; Barański B; Krajewska B
    Med Pr; 1994; 45(4):343-9. PubMed ID: 7968503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Activity of polymorphic N-acetyltransferase in epilepsy].
    Barannikov AS; Trubnikov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(6):857-61. PubMed ID: 4024808
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.